Molecularity Compliance Consulting

Where Science Meets Compliance

Molecularity helps biotechnology, pharmaceutical, medical device, and healthcare organizations navigate quality, regulatory, and clinical compliance challenges — grounded in science, not just standards.

Schedule a Consultation Explore Services

Science

Molecular biology foundation
behind every recommendation

Quality

GxP systems built for
sustainable compliance

Regulatory

Strategic guidance across
FDA, EMA, and MHRA

About Molecularity

Many understand
regulations.
Few understand the science.

Molecularity was founded to bridge a persistent gap in the life sciences consulting industry: advisors who understand either the regulatory framework or the underlying biology, but rarely both with equal depth.

Founded by a molecular biologist and regulatory affairs professional with 15+ years of industry experience, Molecularity provides strategic support across the full product lifecycle — from early development through commercial operations and post-approval.

Whether you are preparing for an FDA inspection, building a quality management system, qualifying a critical CDMO, or navigating a complex biologics submission, Molecularity delivers practical, science-driven solutions tailored to your organization's stage of growth and risk profile.

Molecularity operates as an independent consultancy, providing the objectivity and senior-level attention that large firms cannot offer.

Credentials & Experience

PhD, Cellular & Molecular Biology

Regulatory Affairs Certified (RAC-US)

15+ Years in Quality & Regulatory Leadership

Published Scientific Author

FDA, EMA, and MHRA Inspection Support

NDA, BLA, IND, and 510(k) Submission Experience

Biologics, Cell & Gene Therapy Expertise

Clinical Research & GCP Audit Leadership

Services

Expertise across
the GxP landscape

Molecularity provides practical, risk-based compliance solutions tailored to your product type, development stage, and regulatory environment.

⚖️

Regulatory Strategy & Submissions

FDA regulatory strategy, IND, NDA, BLA, and 510(k) support, orphan drug programs, submission review, and regulatory gap assessments.

🏗️

Quality Systems & Compliance

QMS development, SOP authoring, CAPA systems, internal audit programs, quality metrics, and risk management frameworks.

🔍

Inspection Readiness & Remediation

FDA inspection readiness, mock inspections, PAI and PLI support, FDA response strategy, and remediation program management.

📋

Audits & Quality Assessments

GCP, GMP, GLP, GCLP, pharmacovigilance, CSV, TMF, investigator site, CRO, and CMO/CDMO audits.

🔗

Vendor & CDMO Oversight

Vendor qualification, supplier audits, quality agreements, risk assessments, and ongoing oversight programs.

🧬

Advanced Therapeutics

Specialized support for biologics, cell therapies, gene therapies, rare disease programs, and CMC quality in complex modalities.

💊

Clinical Quality & GCP

Clinical quality systems, GCP compliance, TMF assessments, vendor oversight, and clinical inspection readiness.

💻

Data Integrity & Computer Systems

Data integrity assessments, 21 CFR Part 11 compliance, CSV/CSA, eQMS and eDMS implementation support.

🔒

HIPAA & Privacy Compliance

Privacy program development, risk assessments, policy development, workforce training, and incident response support.

Industries Served

Across the life sciences
and healthcare spectrum

Molecularity brings relevant, sector-specific experience across the organizations that develop and deliver innovative therapies.

Biotechnology Cell & Gene Therapy Pharmaceutical Medical Device Diagnostics Clinical Research Organizations CDMOs Healthcare Organizations
Thought Leadership

Contributing to
industry dialogue

Molecularity actively advances industry thinking in quality systems, regulatory science, and inspection readiness.

Real World Evidence Quality

Developing fit-for-purpose quality frameworks for RWE studies, where traditional GCP structures require adaptation.

Inspection Readiness

Practical approaches to building sustained inspection readiness rather than point-in-time preparation programs.

Risk-Based Quality Management

Applying ICH Q9 and Q10 principles pragmatically across organizations at varying stages of quality maturity.

Vendor Oversight

Governance frameworks for complex outsourced operations, including CDMO qualification and ongoing performance oversight.

Regulatory Strategy for Emerging Therapies

Navigating the evolving regulatory landscape for cell and gene therapies, biologics, and rare disease programs.

Data Integrity

Implementing sustainable data governance and integrity programs that satisfy FDA and EMA expectations.

Contact

Let's discuss your compliance challenges.

Whether you are preparing for an FDA inspection, building a quality system, qualifying a critical vendor, responding to findings, or navigating a complex regulatory pathway — Molecularity can help.

Schedule a consultation to discuss your organization's specific needs and how Molecularity can support your compliance goals.

📍

Edgewater, Maryland | Remote & On-Site Available

🌐

www.molecularity.org

📧

#contact